Sepah Yasir J, Umer Masood, Qureshi Asim, Khan Shaista
Department of Surgery (Orthopedics), Aga Khan University Medical College P.O. Box 3500, Karachi-74800 Pakistan.
Cases J. 2009 Sep 1;2:6887. doi: 10.4076/1757-1626-2-6887.
Lymphangiosarcoma following breast cancer is a relatively rare entity, with around 300 cases so far reported worldwide. Affecting the long term survivors of breast cancer, lymphangiosarcoma (Stewart-Traves Syndrome) has a high mortality rate. Since lympedema following radical mastectomy or axillary clearance and radiotherapy seems to be the main predisposing factor, further research regarding modifications in the surgical technique of axillary nodes dissection as well as the development of new chemotherapeutic agents effective in lymphangiosarcoma are required.
乳腺癌后发生的淋巴管肉瘤是一种相对罕见的疾病,目前全球报道的病例约有300例。淋巴管肉瘤(斯图尔特-特拉维斯综合征)影响乳腺癌的长期幸存者,死亡率很高。由于根治性乳房切除术或腋窝清扫及放疗后的淋巴水肿似乎是主要的诱发因素,因此需要进一步研究腋窝淋巴结清扫手术技术的改进以及开发对淋巴管肉瘤有效的新型化疗药物。